All Stories

  1. COVID-19 Research, Public Health and Biomedical Basis
  2. Anticancer Drug Development: Evaluative Architecture
  3. COVID-19 Study: A New Principle Discovery
  4. COVID-19 Study, Diagnostic and Therapeutic Transition
  5. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  6. Bone Metastasis Diagnosis, Blood Biomarker Detections
  7. Anti-metastatic drug development, overview and perspectives
  8. Educational Perspectives for Nursery
  9. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  10. Pulmonary nodules, is there any pathogenesis evidence?
  11. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  12. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  13. Pulmonary Nodules, Surgery or Other Medication
  14. Anti-Metastatic Drug Developments, Utility of More Animal Models
  15. Several approaches for anticancer drug development progress
  16. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  17. COVID-19 infection for metabolic abnormal human beings
  18. Fundamental knowledge for nurses 
  19. Nursery promotion, education and system updating
  20. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  21. Cancer Bone Metastasis, Experimental Study
  22. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  23. Osteoporosis Targeting, Possible Breakthroughs
  24. Neuropsychiatric insights for human suicide
  25. Bone Cancer and Metastasis Trials, Drug Treatment
  26. Neurobiology for human suicide
  27. Bone Disease Treatment Study, Major Pathways
  28. Pathology Study for Human Suicide
  29. Nursery activity and quality, chemistry between doctors and nurses
  30. Nursery education, narrow-range or wide-range
  31. Anticancer drug development, challenge and dilemma
  32. Life Origin on Earth, Knowledge Development
  33. HIV/AIDS treatment, therapeutic strategy break throughs
  34. Suicide Risks and Prevention, Neuropathogenic Study
  35. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  36. General information for nursery
  37. Historical analysis of suicide
  38. Drug sensitivity testing, a unique drug selection strategy
  39. Life Origin on Earth, Biochemical Approaches
  40. Herbal medicine in new era
  41. Nursery service, quality promotion
  42. Patient’s care and nursery in different diseases
  43. New HIV/AIDS Therapeutics
  44. Nursery Service in Modern Days
  45. Cancer Bioinformatics in Cancer Therapy
  46. Individualized Cancer Therapy
  47. Type 2 Diabetes Treatment and Drug Development Study
  48. Hypotheses for Life Origin on Earth, Comparison and Validation
  49. Type 2 Diabetes Study, Introduction and Perspective
  50. Anthocyanins and its biological & therapeutic characters
  51. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  52. Pathology and treatments of obesity
  53. Obesity, Risks and Managements
  54. Keep up the pace of drug development evolution and expenditure
  55. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  56. Drug Combination in Clinical Cancer Treatments
  57. General outlook for individualized cancer therapy
  58. Ebola origin and treatment
  59. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  60. HAART in HIV/AIDS Treatments
  61. Anticancer Drug Development, System Updating and Global Participations
  62. Human suicide study, major disciplines and treatment outcomes
  63. Anticancer drug development
  64. HIV in Human Genomes and Therapeutics
  65. HIV Biotherapy and Natural Chemotherapeutic Agents
  66. Anticancer Drug Combinations, How Far We can Go Through?
  67. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  68. Life Origin on Earth, Insights among Different Arguments
  69. Cancer metastasis treatment, a key drawbacks
  70. The suicide treatment, a new model
  71. HIV Vaccine for Prevention and Cure, A Mission Possible
  72. Zika Therapy
  73. HIV vaccine
  74. Discover Natural Chemical Drugs in Modern Medicines
  75. Mathematics in biomedical science
  76. The origin of HIV
  77. Human suicide study
  78. Pharmacogenetics of Cancer Therapy
  79. Anticancer Drug Sensitivity Testing
  80. New Perspectives of HIV/AIDS Therapy Study
  81. Antidepressant treatment study
  82. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  83. Assistant cancer treatments in the clinic
  84. Drug sensitivity testing in clinical cancer treatments
  85. Anticancer drug combination in the clinic
  86. Anticancer drug pharmacogenomics in cancer chemotherapy
  87. Cost-effectiveness for personalized cancer therapy
  88. Conclusion
  89. Introduction
  90. Discussion
  91. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  92. Anti-diabetic treatments
  93. Anticancer Drug Combinational Study
  94. The Origins of HIV
  95. Anti-diabetic treatments, patho-therapeutic relation
  96. Origin of Ebola, hypothesis
  97. Personalized Cancer Therapy: A Perspective
  98. Pharmacogenomics in human suicide prediction and treatments
  99. Cancer metastasis treatment study and drug developments
  100. Challenge for HIV/AIDS therapy
  101. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  102. Drug Combinations in Cancer Treatments
  103. New Insights into Individualized Antimetastatic Therapy
  104. Anticancer drugs on serum sialic acid level in mice bearing LLC
  105. Genetics in Neural Toxicity of Drugs
  106. Avian flu, pathogenesis and therapeutic study
  107. First Genetic Information Replication in Life Origin on Earth
  108. Origins of Life, A New Cooperative Model
  109. Cancer Metastases and Clinical Therapies
  110. Origins of Life, RNA world or alternative RNA world
  111. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  112. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  113. Antimetastatic Therapies according to Metastatic Cascade
  114. Genetics in antidepressant-induced suicide
  115. Pathology of Drug-induced mania & suicide
  116. Influenza treatment
  117. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  118. Individualized cancer chemotherapy
  119. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  120. Genomic study of antidepressant-induced suicide
  121. Aberrant sialylation in tumor cells
  122. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  123. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  124. Neural toxicity of drugs
  125. Anticancer activity and mechanisms of Bisdioxopiperazines
  126. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  127. 14C-probimane in the mice bearing LLC
  128. Unsatisfactory design of human AIDS genome research
  129. Antidepressant in Cancer Treatment
  130. AIDS and human genome studies, from a hypothesis to systematic approaches
  131. Antidepressants in Human suicide
  132. Mathematical model in therapeutic risk prediction
  133. Fibrinogen in neoplasm metastasis
  134. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  135. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  136. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  137. Individualized cancer chemotheray
  138. Anti-proliferative and chromosome segregation by probimane and MST-16
  139. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  140. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  141. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  142. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  143. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  144. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  145. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  146. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane